|
MX9604400A
(es)
|
1994-03-30 |
1997-12-31 |
Mitokor |
Diagnostico, terapia y modelos celular y animal para enfermedades asociadas con defectos mitocondriales.
|
|
US6472378B2
(en)
|
1998-08-31 |
2002-10-29 |
Pro-Neuron, Inc. |
Compositions and methods for treatment of mitochondrial diseases
|
|
JP2002538167A
(ja)
|
1999-03-03 |
2002-11-12 |
バイオジェン インコーポレイテッド |
脂質の代謝および貯蔵を調節する方法
|
|
GB2350565A
(en)
|
1999-05-28 |
2000-12-06 |
Johnson & Johnson Medical Ltd |
Biological wound dressings comprising mitochondria
|
|
DE19937348A1
(de)
|
1999-08-11 |
2001-02-22 |
Aventis Cropscience Gmbh |
Nukleinsäuremoleküle aus Pflanzen codierend Enzyme, die an der Stärkesynthese beteiligt sind
|
|
JP2004500409A
(ja)
|
2000-03-31 |
2004-01-08 |
ザ ジェネラル ホスピタル コーポレーション |
毛の成長を調節する方法
|
|
EP1325743A4
(en)
|
2000-10-13 |
2004-12-15 |
Chugai Pharmaceutical Co Ltd |
COMPOSITIONS TO IMPROVE FAT METABOLISM
|
|
US20030040475A1
(en)
|
2001-01-16 |
2003-02-27 |
Yasuhiro Toba |
Agents for improving lipid metabolism and reducing high blood pressure
|
|
US7339090B2
(en)
|
2001-02-13 |
2008-03-04 |
Avigenics, Inc. |
Microinjection devices and methods of use
|
|
JP4603192B2
(ja)
|
2001-05-10 |
2010-12-22 |
株式会社カネカ |
毛髪頭皮用組成物
|
|
WO2003012050A2
(en)
|
2001-07-31 |
2003-02-13 |
Northeastern University |
Mitochondrial genome replenishment
|
|
AU2002324645C1
(en)
|
2001-08-08 |
2008-11-06 |
Levesque Biosciences, Inc. |
Compositions and methods for isolation, propagation, and differentiation of human stem cells and uses thereof
|
|
US7138134B2
(en)
|
2001-12-18 |
2006-11-21 |
Arizona Health Consulting Group, Llc |
Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels
|
|
US20050153381A1
(en)
|
2002-02-14 |
2005-07-14 |
Marusich Michael F. |
Immunocapture of mitochondrial protein complexes
|
|
AU2004238375A1
(en)
|
2003-05-13 |
2004-11-25 |
The Regents Of The University Of Colorado |
Diagnostic and therapeutic treatments related to mitochondrial disorders
|
|
WO2004103389A2
(en)
|
2003-05-22 |
2004-12-02 |
Theraptosis Sa |
Means for preventing and treating cellular death and their biological applications
|
|
US7407800B1
(en)
|
2003-09-19 |
2008-08-05 |
Pierce Biotechnology, Inc. |
Method for the isolation of intact mitochondria from cells
|
|
CA2551190A1
(en)
|
2003-12-23 |
2005-07-07 |
Nono Inc. |
Polypeptides for modulating binding of trp channel proteins and trp-associated proteins.
|
|
US20060024277A1
(en)
|
2004-07-27 |
2006-02-02 |
Sivak Hannah N |
Method of skin care and/or treatment using extracts enriched in mitochondria
|
|
JP2006131600A
(ja)
|
2004-11-09 |
2006-05-25 |
R & D Cell-Science Optional Medico:Kk |
発毛促進のためのヒト細胞組成物
|
|
EP3417868A1
(en)
|
2005-06-10 |
2018-12-26 |
Thylabisco AB |
Composition
|
|
AU2012201710B2
(en)
|
2006-05-11 |
2014-01-16 |
Regenics As |
Administration of cells and cellular extracts for rejuvenation
|
|
AT502353B1
(de)
|
2006-06-29 |
2007-07-15 |
Avl List Gmbh |
Verfahren und vorrichtung zur konditionierung eines o2-hältigen gases
|
|
CA2688125A1
(en)
|
2007-05-02 |
2008-11-13 |
The Mclean Hospital Corporation |
Methods and compositions for mitochondrial replacement therapy
|
|
WO2008152640A2
(en)
|
2007-06-13 |
2008-12-18 |
Pluristem Ltd. |
Three dimensional biocompatible scaffolds for ex-vivo expansion and transplantation of stem cells
|
|
WO2009154770A2
(en)
|
2008-06-18 |
2009-12-23 |
The Texas A & M University System |
Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage
|
|
US20110105359A1
(en)
|
2009-10-30 |
2011-05-05 |
Xenotech, Llc |
Cryopreservation of cells and subcellular fractions
|
|
US8338178B2
(en)
|
2010-10-28 |
2012-12-25 |
The Invention Science Fund I, Llc |
Mitochondrial enhancement of cells
|
|
DK2645993T3
(en)
|
2010-12-03 |
2017-02-13 |
Allergan Inc |
Pharmaceutical cream compositions comprising oxymetazoline
|
|
CN113142581B
(zh)
|
2010-12-23 |
2025-07-22 |
阿马曾提斯公司 |
用于改善线粒体功能的组合物和方法
|
|
EP2726601B1
(en)
|
2011-06-29 |
2018-12-26 |
The General Hospital Corporation |
Compositions and methods for enhancing bioenergetic status in female germ cells
|
|
CN102266350A
(zh)
|
2011-07-20 |
2011-12-07 |
黄必录 |
逆转干细胞衰老的方案
|
|
US20130022666A1
(en)
|
2011-07-20 |
2013-01-24 |
Anna Brzezinska |
Methods and compositions for transfer of mitochondria into mammalian cells
|
|
CN102293178A
(zh)
|
2011-08-28 |
2011-12-28 |
黄必录 |
使个体去衰老的方法
|
|
IL282198B2
(en)
*
|
2011-09-11 |
2025-11-01 |
Minovia Therapeutics Ltd |
Compositions of functional mitochondria and uses thereof
|
|
CN104066837B
(zh)
|
2011-12-02 |
2020-12-08 |
菲特治疗公司 |
增强的干细胞组合物
|
|
US8648034B2
(en)
|
2011-12-09 |
2014-02-11 |
Changhua Christian Hospital |
Method and applications of peptide-mediated mitochondrial delivery system
|
|
WO2013149064A1
(en)
|
2012-03-30 |
2013-10-03 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Uridine diphosphate compounds as mobilizers of hematopoietic progenitor cells
|
|
US10702556B2
(en)
|
2012-05-16 |
2020-07-07 |
Minovia Therpautices Ltd. |
Compositions and methods for inducing angiogenesis
|
|
WO2014091312A2
(en)
|
2012-12-10 |
2014-06-19 |
Regenics As |
Use of cellular extracts for skin rejuvenation
|
|
ES2860573T3
(es)
|
2013-02-19 |
2021-10-05 |
Childrens Medical Center |
Células madre ABCB5(+) para el tratamiento de enfermedades oculares
|
|
DE102013225588A1
(de)
|
2013-12-11 |
2014-04-17 |
Henkel Ag & Co. Kgaa |
Verwendung und Mittel zur Verbesserung der Haarstruktur
|
|
KR20240164967A
(ko)
|
2014-02-04 |
2024-11-21 |
카이트 파마 인코포레이티드 |
B 세포 악성종양 및 다른 암을 치료하는데 유용한 자가 t 세포 및 그의 조성물의 생산 방법
|
|
EP2918458B1
(en)
|
2014-03-11 |
2016-12-07 |
Autoliv Development AB |
A vehicle braking arrangement
|
|
US20170080030A1
(en)
|
2014-03-17 |
2017-03-23 |
University Of Virginia Patent Foundation |
Compositions and methods for treating retinopathy
|
|
CN103976935A
(zh)
|
2014-05-28 |
2014-08-13 |
广州市白云区天芳化妆品厂 |
一种抗衰原液及其制备方法
|
|
US10738278B2
(en)
|
2014-07-15 |
2020-08-11 |
Juno Therapeutics, Inc. |
Engineered cells for adoptive cell therapy
|
|
WO2016008937A1
(en)
|
2014-07-16 |
2016-01-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for the intercellular transfer of isolated mitochondria in recipient cells
|
|
WO2016037587A1
(en)
|
2014-09-11 |
2016-03-17 |
Taiwan Mitochondrion Applied Technology Co., Ltd |
Pharmaceutical compositions for treating degenerative neurological disease with mitocells
|
|
JP6441472B2
(ja)
|
2014-09-30 |
2018-12-19 |
台灣粒線體應用技術股▲扮▼有限公司Ｔａｉｗａｎ Ｍｉｔｏｃｈｏｎｄｒｉｏｎ Ａｐｐｌｉｅｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏ．，Ｌｔｄ． |
活性成分として外因性ミトコンドリアを含む組成物、ならびにその使用およびそのための細胞修復法
|
|
EP3219322A4
(en)
|
2014-11-14 |
2018-06-20 |
JCR Pharmaceuticals CO., LTD. |
Muscular dystrophy therapeutic agent containing pluripotent stem cells derived from dental pulp
|
|
GB201500427D0
(en)
|
2015-01-12 |
2015-02-25 |
Isis Innovation |
Method
|
|
WO2016112425A1
(en)
|
2015-01-14 |
2016-07-21 |
Calix Ltd |
Improved pathogen inhibitor
|
|
US20180030413A1
(en)
|
2015-02-26 |
2018-02-01 |
Minovia Therapeutics Ltd. |
Mammalian cells enriched with functional mitochondria
|
|
US10537594B2
(en)
|
2015-02-27 |
2020-01-21 |
University Of Connecticut |
Targeted transplantation of mitochondria to hepatocytes
|
|
KR20180019613A
(ko)
|
2015-05-28 |
2018-02-26 |
셀룰래리티, 인코포레이티드 |
태반-유래 줄기 세포 및 그의 재생 엔진 복구, 프로테옴 결함 수정 및 노화 객체의 수명 연장 용도
|
|
US20170151287A1
(en)
|
2015-11-30 |
2017-06-01 |
Flagship Ventures Management, Inc. |
Methods and compositions of chondrisomes
|
|
ES3057779T3
(en)
|
2016-01-15 |
2026-03-04 |
Childrens Medical Ct Corp |
Therapeutic use of mitochondria and combined mitochondrial agents
|
|
AU2017354272A1
(en)
|
2016-11-03 |
2019-05-23 |
Exostem Biotec Ltd. |
Mesenchymal stem cells populations, their products, and use thereof
|
|
WO2018088874A1
(ko)
|
2016-11-14 |
2018-05-17 |
주식회사 파이안바이오테크놀로지 |
외래 미토콘드리아를 세포로 전달하는 방법
|
|
CN110022884A
(zh)
|
2016-11-30 |
2019-07-16 |
白雁生物技术公司 |
含有线粒体的药物组合物
|
|
US20200023005A1
(en)
|
2017-03-26 |
2020-01-23 |
Minovia Therapeutics Ltd. |
Mitochondrial compositions and methods for treatment of skin and hair
|
|
US12502408B2
(en)
|
2018-07-22 |
2025-12-23 |
Minovia Therapeutics Ltd. |
Mitochondrial augmentation therapy for primary mitochondrial diseases
|
|
WO2020021541A1
(en)
|
2018-07-22 |
2020-01-30 |
Minovia Therapeutics Ltd. |
Mitochondrial augmentation therapy with stem cells enriched with functional mitochondria
|
|
WO2020021539A1
(en)
|
2018-07-22 |
2020-01-30 |
Minovia Therapeutics Ltd. |
Mitochondrial augmentation therapy of muscle diseases
|
|
EP3823644A4
(en)
|
2018-07-22 |
2022-06-08 |
Minovia Therapeutics Ltd. |
MITOCHONDRIAL AUGMENTATION THERAPY OF PANCREATIC DISEASES
|
|
WO2020021537A1
(en)
|
2018-07-22 |
2020-01-30 |
Minovia Therapeutics Ltd. |
Mitochondrial augmentation therapy of liver diseases
|
|
WO2020021535A1
(en)
|
2018-07-22 |
2020-01-30 |
Minovia Therapeutics Ltd. |
Mitochondrial augmentation therapy of ocular diseases
|
|
JP7524157B2
(ja)
|
2018-07-22 |
2024-07-29 |
ミノヴィア セラピューティクス リミテッド |
脳疾患のミトコンドリア増強療法
|
|
KR20210045435A
(ko)
|
2018-08-14 |
2021-04-26 |
이멜 바이오테라퓨틱스, 인코포레이티드. |
미토콘드리아 질환 또는 장애 및 헤테로플라스미를 치료하기 위한 방법 및 조성물
|
|
CA3138566A1
(en)
|
2019-04-30 |
2020-11-05 |
Larimar Therapeutics, Inc. |
Frataxin-sensitive markers for determining effectiveness of frataxin replacement therapy
|
|
MX2022012157A
(es)
|
2020-03-31 |
2023-02-15 |
Minovia Therapeutics Ltd |
Celulas geneticamente modificadas enriquecidas con mitocondrias y usos de estas.
|